BNET Industries
Martek Biosciences Corp. (MATK) is in the Pharma Industry
- Revenue
- Oct 31 2007
- $306.8M
- Profit
- Oct 31 2007
- $32.0M
- Market Cap
- Aug 27 2008
- $1.1B
Latest News and Analysis
Six Ways to Profit from the Mini-Baby Boom
Option Dragon submits: Population growth is the lifeblood of all civilizations and societies. It is a carried promise of further development and prosperity in a nation. The U.S. is in fact in the midst of a mini baby boom and there are long term opportunities here for the looking. A...
Martek Biosciences Corporation F2Q08 (Qtr End 04/30/2008) Earnings Call Transcript
Martek Biosciences Corporation F2Q08 (Qtr End 04/30/2008) Earnings Call Transcript
Martek Biosciences F1Q08 (Qtr End 01/31/08) Earnings Call Transcript
Martek Biosciences F1Q08 (Qtr End 01/31/08) Earnings Call Transcript
Additional Resources
Martek to Present at Upcoming Canaccord Adams Conference
COLUMBIA, Md., July 29 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced today that it will be presenting at the upcoming Canaccord Adams 28th Annual Global Growth Conference in Boston, MA. The conference is being held August 12 - 14, 2008 at the InterContinental Boston hotel. Steve Dubin, CEO...
Dow AgroSciences LLC and Martek Biosciences Corporation entered into a collaborative agreement
Dow AgroSciences LLC and Martek Biosciences Corporation entered into a collaborative agreement to jointly develop and commercialize a canola seed that produces the omega-3 fatty acid docosahexaenoic acid DHA for the food industry...
Results of Study in Pre-School Children Published in Clinical Pediatrics Adds to Support for Importance of Dietary DHA Intake
COLUMBIA, Md., June 26 /PRNewswire-FirstCall/ -- A study published in the May issue of Clinical Pediatrics indicates that higher DHA levels are associated with improved listening comprehension and vocabulary skills in preschool children. The study, "Assessing the Effect of Docosahexaenoic Acid on Cognitive Functions in Healthy,...
Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHA™
COLUMBIA, Md., June 25 /PRNewswire-FirstCall/ -- Martek Biosciences announced today that life'sDHATM, its patented, vegetarian form of DHA-omega 3 essential for infant brain and eye development, is now available to Eastern European consumers in the new Pregnium prenatal supplement from Walmark. Featuring 200 mg per...
Zacks Releases Four Powerful "Buy" Stocks: Martek Biosciences, Monsanto, GulfMark Offshore and Whiting Petroleum
CHICAGO -- Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income,...
Martek's life'sDHA Now Available in WhiteWave's Rachel's Yogurt
FOOD AND BEVERAGE CLOSE-UP-9 June 2008-Martek's life'sDHA Now Available in WhiteWave's Rachel's YogurtC2008 - CloseUpMedia - newsdesk@closeupmedia.com Martek Biosciences announced that life'sDHA, its patented, vegetarian form of DHA omega-3 for brain, eye and heart health, is now available in Rachel's Wickedly Delicious yogurt at mainstream...
The Daily Record News Summaries: June 5, 2008
Martek's profit soars Martek Biosciences Corp., of Columbia, a manufacturer of nutritional oils for foods and baby formula, said second-quarter profit jumped 89 percent on global infant formula sales. Net income was $9.2 million, or 28 cents per diluted share, compared with $4.9...
Martek's life'sDHA™ Now Available in Rachel's™ Yogurt at Grocery Retailers Nationwide
COLUMBIA, Md., June 4 /PRNewswire-FirstCall/ -- Martek Biosciences announced today that life'sDHATM, its patented, vegetarian form of DHA omega-3 for brain, eye and heart health, is now available in Rachel's Wickedly DeliciousR yogurt at mainstream grocery retailers across the U.S. WhiteWave Foods launched the Rachel's brand featuring...
Martek Announces Second Quarter 2008 Financial Results
Second Quarter Highlights: - Record revenues of $90.7 million, up 18% from the prior year's second quarter - Earnings per share of $0.28, an increase of approximately 87% over last year's second quarter - Operating cash flow of $23.6 million (Year-to-date...
Martek Biosciences, Dow unit collaborate
Martek Biosciences Corp., of Columbia, and Dow AgroSciences LLC, of Indianapolis, announced a collaborative agreement to jointly develop and commercialize a canola seed that produces the omega-3 fatty acid DHA docosahexaenoic acid. Under the terms of the agreement, Martek and Dow AgroSciences will co-develop the canola seed, which will produce...
Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
COLUMBIA, Md. and INDIANAPOLIS, May 29 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC and Martek Biosciences Corporation today announced a collaborative agreement to jointly develop and commercialize a canola seed that produces the omega-3 fatty acid, DHA docosahexaenoic acid. Under the terms of the agreement, Martek and Dow AgroSciences...
Martek to Present at Upcoming Needham Conference
COLUMBIA, Md., May 29 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced today that it will be presenting at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference in New York. The conference is being held June 11 - 12, 2008 at the New York Palace Hotel....
Martek Announces Addition to Its Board of Directors
COLUMBIA, Md., May 16 /PRNewswire-FirstCall/ -- Martek Biosciences today announced the election of Michael G. Devine to its board of directors and audit committee. Mr. Devine retired from public accounting in 2003 after a successful 24-year career primarily spent as a partner with Arthur Andersen LLP...
Zacks #1 Rank Top Performers: LaBranche & Co, McMoRan, Big Lots, Martek Biosciences and Stone Energy
CHICAGO -- Zacks.com announces the latest list of top performing Zacks #1 Rank ("strong buy") stocks. The stocks on the prestigious list with the highest returns last week were LaBranche & Co. Inc. (NYSE: LAB), McMoRan Exploration Company (NYSE: MMR), Big Lots, Inc. (NYSE: BIG), Martek Biosciences Corporation (NASDAQ: MATK)...
Federal judge in Baltimore approves $6M settlement of Martek suit
A federal judge in Baltimore has granted final approval of the $6 million settlement of the securities class action against Martek Biosciences Corp. in which shareholders alleged the Columbia-based nutritional supplements company misled investors about its financial prospects in late 2005. The order signed by U.S. District...
UM SCIENTISTS FIND KEY TO LOW-COST ETHANOL IN CHESAPEAKE BAY.
The secret to making an inexpensive substitute to gasoline may come from a bacterium found eating marsh grass in the Chesapeake Bay. A chance discovery not detected in the Bay since, the bacterium, called Saccharophagus degradans, can create a mixture of...
Australia's Leading Juice Company Launches Juice Blend with Martek's life'sDHA™
COLUMBIA, Md., March 13 /PRNewswire-FirstCall/ -- Martek Biosciences announced today that life'sDHATM, its patented, vegetarian form of DHA-omega 3 for brain, eye and heart health, is available in the new Berri Australian Fresh Omega-3 for Heart & Mind juice-blend from National Foods, Australia's No. 1 juice company. National...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View by Content TypeClose
- Incorporated: 1985
- CEO: Mr. Steve Dubin
- Employees: 515
Martek Biosciences develops, manufactures and sells products derived from microalgae, fungi and other microbes. Co.'s products and services include nutritional oils for infant formula, dietary supplements, foods and beverages, as well as contract manufacturing services. Co.'s nutritional oils are comprised of fatty acid components, primarily docosahexaenoic acid (DHA) and arachidonic acid (ARA), which it sells under the names life'sDHA™, DHASCO®, Neuromins®, ARASCO® and life'sARA™, while its contract manufacturing services relate primarily to the production of enzymes, specialty chemicals, vitamins, agricultural specialties and intermediates for both large and small companies.
Key Competitors
Martek Biosciences Corp. Company Info
Board of Directors
Mr. Robert J. Flanagan
Chairman
Mr. Steve Dubin
Mr. Michael G. Devine
Mr. Harry J. D'Andrea
Mrs. Polly B. Kawalek
Mr. Jerome C. Keller
Mr. Douglas J. MacMaster Jr.
Mr. Robert H. Mayer
Mr. Eugene H. Rotberg
Mr. James R. Beery
Contact Information
6480 Dobbin Road
Columbia, MD
410 740-0081